Search research articles
Contact Us
Filters
Showing results (81-90 of 114) with videos related to
Page
of 12
Sort By:
Journal of Alzheimer'S Disease : JAD
|
March 15, 2021
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus
Heikki Lukkarinen, Ina Tesseur, Darrel Pemberton, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 15, 2019
Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial
Norihiro Kogame, Ply Chichareon, Kenneth De Wilder, et al.
JACC. Cardiovascular Interventions
|
February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)
Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
International Journal of Cardiology
|
August 10, 2025
Deferred revascularization of left main stenosis based on instantaneous wave-free ratio: Long-term clinical outcomes from the PHYNAL registry
Alice Benedetti, Chiara Fusi, Mathieu Coeman, et al.
Lancet (London, England)
|
September 1, 2018
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx, Marco Valgimigli, Peter Jüni, et al.
Journal of the American Heart Association
|
March 1, 2022
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial
Felice Gragnano, Marcel Zwahlen, Pascal Vranckx, et al.
JACC. Cardiovascular Interventions
|
October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial
Stephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 2, 2022
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
Masafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, et al.
Acta Cardiologica
|
August 7, 2020
The evolution of the CTO-PCI landscape in Belgium and Luxembourg: a four-year appraisal
Ward Eertmans, Peter Kayaert, Johan Bennett, et al.
Lancet (London, England)
|
September 8, 2018
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial
Alexandra Lansky, William Wijns, Bo Xu, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 114) with videos related to
Sort By:
Page
of 12
Journal of Alzheimer'S Disease : JAD
|
March 15, 2021
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus
Heikki Lukkarinen, Ina Tesseur, Darrel Pemberton, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 15, 2019
Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial
Norihiro Kogame, Ply Chichareon, Kenneth De Wilder, et al.
JACC. Cardiovascular Interventions
|
February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)
Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
International Journal of Cardiology
|
August 10, 2025
Deferred revascularization of left main stenosis based on instantaneous wave-free ratio: Long-term clinical outcomes from the PHYNAL registry
Alice Benedetti, Chiara Fusi, Mathieu Coeman, et al.
Lancet (London, England)
|
September 1, 2018
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx, Marco Valgimigli, Peter Jüni, et al.
Journal of the American Heart Association
|
March 1, 2022
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial
Felice Gragnano, Marcel Zwahlen, Pascal Vranckx, et al.
JACC. Cardiovascular Interventions
|
October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial
Stephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 2, 2022
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
Masafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, et al.
Acta Cardiologica
|
August 7, 2020
The evolution of the CTO-PCI landscape in Belgium and Luxembourg: a four-year appraisal
Ward Eertmans, Peter Kayaert, Johan Bennett, et al.
Lancet (London, England)
|
September 8, 2018
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial
Alexandra Lansky, William Wijns, Bo Xu, et al.
Page
of 12